225 related articles for article (PubMed ID: 36449294)
1. Statin Use and Survival Among Men Receiving Androgen-Ablative Therapies for Advanced Prostate Cancer: A Systematic Review and Meta-analysis.
Jayalath VH; Clark R; Lajkosz K; Fazelzad R; Fleshner NE; Klotz LH; Hamilton RJ
JAMA Netw Open; 2022 Nov; 5(11):e2242676. PubMed ID: 36449294
[TBL] [Abstract][Full Text] [Related]
2. Mortality associated with statins in men with advanced prostate cancer treated with androgen deprivation therapy.
Wu SY; Fang SC; Shih HJ; Wen YC; Shao YJ
Eur J Cancer; 2019 May; 112():109-117. PubMed ID: 30827745
[TBL] [Abstract][Full Text] [Related]
3. The Association Between Statin Use and Outcomes in Patients Initiating Androgen Deprivation Therapy.
Hamilton RJ; Ding K; Crook JM; O'Callaghan CJ; Higano CS; Dearnaley DP; Horwitz EM; Goldenberg SL; Gospodarowicz MK; Klotz L
Eur Urol; 2021 Apr; 79(4):446-452. PubMed ID: 33390282
[TBL] [Abstract][Full Text] [Related]
4. The impact of statins in combination with androgen deprivation therapyin patients with advanced prostate cancer: A large observational study.
Anderson-Carter I; Posielski N; Liou JI; Khemees TA; Downs TM; Abel EJ; Jarrard DF; Richards KA
Urol Oncol; 2019 Feb; 37(2):130-137. PubMed ID: 30528885
[TBL] [Abstract][Full Text] [Related]
5. Statin Use at the Time of Initiation of Androgen Deprivation Therapy and Time to Progression in Patients With Hormone-Sensitive Prostate Cancer.
Harshman LC; Wang X; Nakabayashi M; Xie W; Valenca L; Werner L; Yu Y; Kantoff AM; Sweeney CJ; Mucci LA; Pomerantz M; Lee GS; Kantoff PW
JAMA Oncol; 2015 Jul; 1(4):495-504. PubMed ID: 26181260
[TBL] [Abstract][Full Text] [Related]
6. Associations between statin use and progression in men with prostate cancer treated with primary androgen deprivation therapy.
Mikkelsen MK; Thomsen FB; Berg KD; Jarden M; Larsen SB; Hansen RB; Brasso K
Scand J Urol; 2017 Dec; 51(6):464-469. PubMed ID: 28831860
[TBL] [Abstract][Full Text] [Related]
7. The effect of statins on advanced prostate cancer patients with androgen deprivation therapy or abiraterone/enzalutamide: A systematic review and meta-analysis.
Yang H; Pang L; Hu X; Wang W; Xu B; Zhang X; Liu L
J Clin Pharm Ther; 2020 Jun; 45(3):488-495. PubMed ID: 31951037
[TBL] [Abstract][Full Text] [Related]
8. Intermittent vs Continuous Androgen Deprivation Therapy for Prostate Cancer: A Systematic Review and Meta-analysis.
Magnan S; Zarychanski R; Pilote L; Bernier L; Shemilt M; Vigneault E; Fradet V; Turgeon AF
JAMA Oncol; 2015 Dec; 1(9):1261-9. PubMed ID: 26378418
[TBL] [Abstract][Full Text] [Related]
9. Association of androgen deprivation therapy with cardiovascular death in patients with prostate cancer: a meta-analysis of randomized trials.
Nguyen PL; Je Y; Schutz FA; Hoffman KE; Hu JC; Parekh A; Beckman JA; Choueiri TK
JAMA; 2011 Dec; 306(21):2359-66. PubMed ID: 22147380
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Abiraterone Acetate and Docetaxel with Androgen Deprivation Therapy in High-risk and Metastatic Hormone-naïve Prostate Cancer: A Systematic Review and Network Meta-analysis.
Wallis CJD; Klaassen Z; Bhindi B; Goldberg H; Chandrasekar T; Farrell AM; Boorjian SA; Kulkarni GS; Karnes RJ; Satkunasivam R
Eur Urol; 2018 Jun; 73(6):834-844. PubMed ID: 29037513
[TBL] [Abstract][Full Text] [Related]
11. Statin Use and Prostate Cancer Survival in the Finnish Randomized Study of Screening for Prostate Cancer.
Murtola TJ; Peltomaa AI; Talala K; Määttänen L; Taari K; Tammela TLJ; Auvinen A
Eur Urol Focus; 2017 Apr; 3(2-3):212-220. PubMed ID: 28753762
[TBL] [Abstract][Full Text] [Related]
12. The Effects of Statins on Prostate Cancer Patients Receiving Androgen Deprivation Therapy or Definitive Therapy: A Systematic Review and Meta-Analysis.
Hou YC; Shao YH
Pharmaceuticals (Basel); 2022 Jan; 15(2):. PubMed ID: 35215243
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and Safety of Combined Androgen Deprivation Therapy (ADT) and Docetaxel Compared with ADT Alone for Metastatic Hormone-Naive Prostate Cancer: A Systematic Review and Meta-Analysis.
Botrel TE; Clark O; Lima Pompeo AC; Horta Bretas FF; Sadi MV; Ferreira U; Borges Dos Reis R
PLoS One; 2016; 11(6):e0157660. PubMed ID: 27308831
[TBL] [Abstract][Full Text] [Related]
14. Statin use and outcomes of oncological treatment for castration-resistant prostate cancer.
Peltomaa AI; Talala K; Taari K; Tammela TLJ; Auvinen A; Murtola TJ
Sci Rep; 2023 Nov; 13(1):18866. PubMed ID: 37914793
[TBL] [Abstract][Full Text] [Related]
15. Prostate cancer prognosis after initiation of androgen deprivation therapy among statin users. A population-based cohort study.
Peltomaa AI; Raittinen P; Talala K; Taari K; Tammela TLJ; Auvinen A; Murtola TJ
Prostate Cancer Prostatic Dis; 2021 Sep; 24(3):917-924. PubMed ID: 33790420
[TBL] [Abstract][Full Text] [Related]
16. Prostate cancer survival among statin users after prostatectomy in a Finnish nationwide cohort.
Joentausta RM; Rannikko A; Murtola TJ
Prostate; 2019 May; 79(6):583-591. PubMed ID: 30652328
[TBL] [Abstract][Full Text] [Related]
17. Association of Gleason Grade With Androgen Deprivation Therapy Duration and Survival Outcomes: A Systematic Review and Patient-Level Meta-analysis.
Kishan AU; Wang X; Seiferheld W; Collette L; Sandler KA; Sandler HM; Bolla M; Maingon P; De Reijke T; Hanks GE; Nickols NG; Rettig M; Drakaki A; Reiter RE; Spratt DE; Kupelian PA; Steinberg ML; King CR
JAMA Oncol; 2019 Jan; 5(1):91-96. PubMed ID: 30326032
[TBL] [Abstract][Full Text] [Related]
18. Addition of androgen receptor-targeted agents to androgen-deprivation therapy and docetaxel in metastatic hormone-sensitive prostate cancer: a systematic review and meta-analysis.
Maiorano BA; De Giorgi U; Roviello G; Messina C; Altavilla A; Cattrini C; Mennitto A; Maiello E; Di Maio M
ESMO Open; 2022 Oct; 7(5):100575. PubMed ID: 36152486
[TBL] [Abstract][Full Text] [Related]
19. Association between statins and clinical outcomes among men with prostate cancer: a systematic review and meta-analysis.
Raval AD; Thakker D; Negi H; Vyas A; Kaur H; Salkini MW
Prostate Cancer Prostatic Dis; 2016 Jun; 19(2):151-62. PubMed ID: 26782711
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
